HEMEDICUS Accreditation Renewed
To view this as a PDF click here.
Parsippany, NJ – April 10, 2019 – Frontline Medical Communications is pleased to announce Hemedicus, an accredited continuing medical education provider, has successfully completed the Accreditation Council™ for Continuing Medical Education (ACCME) reaccreditation process.
Upon announcing the achievement, Managing Director, MDedge™ Hematology & Oncology, Frank Iorio, commented, “this renewed accreditation clearly demonstrates the leadership of the Hemedicus staff in delivering high-quality CME programs that meet rigorous standards for educational excellence and independence.”
Hemedicus, an independent ACCME accredited continuing medical education company, aims to improve physician competence and enhance physician performance in practice by offering accredited educational programs in the fields of hematology, oncology, and immunology. Hemedicus produces live events, monographs, webcasts, podcasts, slide kits, and other print and digital educational materials.
Participation in accredited CME helps physicians meet requirements for maintenance of licensure and certification, credentialing, membership in professional societies, and other professional privileges. By availing themselves of accredited CME, physicians can count on a learning environment free bias and can stay current on best practices, enabling them to deliver evidenced-based, effective patient care.
For information on working with Hemedicus, contact Robin Simak, VP, Managing Director, CME Compliance by phone at 973-206-8088 or via email at [email protected].
Hemedicus is an independent ACCME accredited continuing medical education company that specializes in hematology, oncology, and immunology. The Hemedicus staff is comprised of professionals with backgrounds that include academic science, medical education project management, and publishing, who have close working relationships with field leaders, journal editors, and medical societies. Consequently, Hemedicus brings a unique perspective and an unmatched knowledge base to its many educational projects. Hemedicus designs its educational activities—from CME-accredited stand-alone conferences, workshops, and satellite symposia to post-program CME enduring materials—to fill the learning gaps created by the fast pace of advances in medical and scientific knowledge. Hemedicus handles all aspects of the activities, from inception to completion, including activity evaluations and outcomes surveys with the goal of improving physician competence and enhancing physician performance in practice.
Frontline Medical Communications Inc. is one of the healthcare industry’s largest medical communications companies and a leader in digital, print, and live events. The Company leads in HCP-level targeting and is ranked 1st in combined web and print engagements. With MDedge™, our state-of-the-art integrated web portal, and audited email database, FMC meets the marketing challenges of our clients with superior reach, optimal sponsorship opportunities, and flexible advertising programs. We reach 1.2 million+ physicians, NPs, PAs, HCPs, and key healthcare decision makers through more than 30 media brands serving 20 distinct markets, who access our content through an array of digital, print, and face to face channels and social media platforms. FMC delivers award-winning, indexed, clinical reviews; practice and policy information; and medical news daily from on-site reporting at major medical meetings, many in collaboration with notable societies, medical associations, and opinion leaders. FMC produces live events, digital click-for-credit, and CME through affiliation with Global Academy for Medical Education, LLC (globalacademycme.com) and Hemedicus (www.hemedicus.com). Visit frontlinemedcom.com | Twitter | Facebook | LinkedIn.
Frank Iorio, Managing Director, MDedge Hematology & Oncology, [email protected]
Frontline Medical Communications
Corporate office: 7 Century Drive, Suite 302
Parsippany, NJ 07054-4609 | Main: 973.206.3434 | Fax: 973.206.9378